NSAIDs like ibuprofen, naproxen, and aspirin relieve pain by blocking COX enzymes that produce prostaglandins — but that same mechanism causes stomach irritation and can damage kidneys and the cardiovascular system with prolonged use. Celecoxib (a COX-2 selective inhibitor) offers less GI risk but still carries cardiovascular concerns, especially at higher doses. NSAIDs interact significantly with blood thinners, ACE inhibitors, diuretics, and other common medications, so always check for interactions before combining them.
NSAIDs Explained: Ibuprofen, Naproxen, Aspirin & More
MEDICAL DISCLAIMER — This article is for educational purposes only. Before starting, stopping, or changing any NSAID regimen, especially if you have kidney disease, heart disease, ulcers, or take blood thinners, consult your healthcare provider or pharmacist.
NSAIDs — nonsteroidal anti-inflammatory drugs — are among the most widely used medications on earth. Billions of doses are taken every year for everything from headaches to arthritis to menstrual cramps. Yet despite being available over the counter, they carry real risks that aren't always appreciated, and they interact meaningfully with a surprisingly long list of other drugs. Understanding how NSAIDs work, how they differ from each other, who should avoid them, and what they interact with gives you the foundation to use them safely.
How NSAIDs Work: The COX Story
All NSAIDs share a core mechanism: they inhibit enzymes called cyclooxygenases — specifically COX-1 and COX-2. These enzymes are responsible for synthesizing prostaglandins, a family of lipid signaling molecules with wide-ranging effects throughout the body.
Prostaglandins amplify pain signals at the site of tissue damage, drive the inflammatory response (swelling, redness, warmth), raise body temperature in fever, and protect the lining of the stomach and intestines. When NSAIDs block COX enzymes and reduce prostaglandin synthesis, they simultaneously relieve pain, reduce inflammation, lower fever, and — as an unfortunate side effect — weaken the stomach's protective mechanisms.
COX-1 vs. COX-2: Why It Matters
COX-1 is a constitutive enzyme — meaning it runs continuously in normal, healthy cells and maintains the gastric mucosa, supports kidney function, and enables platelet aggregation. COX-2 is largely inducible — it gets switched on in response to injury and inflammation and is the primary driver of inflammatory prostaglandins. Most traditional NSAIDs inhibit both enzymes. Inhibiting COX-2 provides the therapeutic benefit; inhibiting COX-1 causes most of the gastrointestinal side effects. This distinction drove the development of COX-2 selective inhibitors (coxibs), most notably celecoxib.
The Major NSAIDs Compared
| Drug | Brand Name(s) | OTC / Rx | Duration | COX Selectivity |
|---|---|---|---|---|
| Ibuprofen | Advil, Motrin | Both | 4–6 hours | Non-selective |
| Naproxen | Aleve, Naprosyn | Both | 8–12 hours | Non-selective |
| Aspirin | Bayer, Ecotrin | OTC | Irreversible | Non-selective |
| Celecoxib | Celebrex | Rx only | 12 hours | COX-2 selective |
| Meloxicam | Mobic | Rx only | 24 hours | Preferential COX-2 |
| Diclofenac | Voltaren | Both | 6–8 hours | Preferential COX-2 |
| Indomethacin | Indocin | Rx only | 4–6 hours | Non-selective |
| Ketorolac | Toradol | Rx only | 4–6 hours | Non-selective |
Key Differences Between NSAIDs
Speed of Onset
Ibuprofen reaches peak plasma concentration within about 1–2 hours and is known for its relatively rapid onset — which is part of why it's a popular choice for acute pain like headaches and menstrual cramps. Naproxen takes longer (2–4 hours to peak) but its longer duration means fewer doses per day. Ketorolac, available only by prescription and limited to 5 days of use, is one of the most potent NSAIDs for acute pain and is often used in hospital and post-surgical settings.
Duration of Action
Naproxen's 8–12 hour duration makes it convenient for conditions requiring sustained anti-inflammatory coverage. Meloxicam's once-daily dosing makes it particularly practical for chronic conditions like osteoarthritis. Aspirin is the extreme outlier: it irreversibly inhibits COX-1 in platelets by permanently acetylating the enzyme. Since platelets cannot synthesize new proteins (they have no nucleus), platelet function does not recover until the body makes new platelets — a process that takes 7–10 days. This is what makes low-dose aspirin useful for long-term cardiovascular protection, and what makes it risky in surgical patients.
Aspirin and Cardiovascular Protection
Low-dose aspirin (81 mg) has been used for decades in secondary prevention — meaning people who have already had a heart attack or stroke. By permanently blocking platelet COX-1, it prevents the platelet aggregation that contributes to arterial clots. However, updated guidance from the U.S. Preventive Services Task Force now advises against initiating low-dose aspirin for primary prevention (people who have not yet had a cardiac event) in most adults over 60, because the bleeding risks outweigh the modest cardiovascular benefit in those without established disease. If you're currently taking daily aspirin, do not stop without discussing it with your doctor.
Celecoxib: Lower GI Risk, Higher Cardiovascular Concern
Celecoxib's COX-2 selectivity means it largely spares COX-1 in the stomach, resulting in meaningfully fewer gastric ulcers and GI bleeds compared to non-selective NSAIDs. However, COX-2 plays a role in vascular tone and platelet regulation, and inhibiting it shifts the balance toward vasoconstriction and thrombosis. Clinical trials — most notably the VIGOR trial and subsequent meta-analyses — showed elevated cardiovascular event rates with COX-2 inhibitors. Two COX-2 selective NSAIDs (rofecoxib/Vioxx and valdecoxib/Bextra) were withdrawn from the market for this reason. Celecoxib, the remaining coxib, is considered acceptable for patients with GI risk who require NSAID therapy, but it is avoided in those with established cardiovascular disease.
OTC Versus Prescription Dosing
The distinction between OTC and prescription NSAID use is largely a matter of dose. Ibuprofen is sold OTC in 200–400 mg doses, taken every 4–6 hours. Prescription ibuprofen reaches 600–800 mg three to four times daily — significantly more anti-inflammatory exposure, with correspondingly more GI and renal risk. Similarly, naproxen is sold OTC as 220 mg doses (Aleve) taken twice daily; prescription naproxen reaches 500 mg twice daily for inflammatory conditions. Higher doses are more effective for inflammatory conditions like rheumatoid arthritis, but they require more careful monitoring.
Who Should Avoid NSAIDs
NSAIDs are contraindicated or require extra caution in several populations:
- Kidney disease — Prostaglandins maintain renal blood flow; blocking them in patients with marginal kidney function can precipitate acute kidney injury. NSAIDs are among the most common drug-induced causes of kidney injury.
- Active peptic ulcers or history of GI bleeding — COX-1 inhibition weakens the gastric mucosa's defenses and is a major cause of ulcers and upper GI hemorrhage.
- Heart failure — NSAIDs cause fluid and sodium retention, which worsens heart failure and can precipitate acute decompensation.
- Third trimester of pregnancy — NSAIDs are associated with premature closure of the ductus arteriosus and are contraindicated.
- Elderly patients — Higher baseline GI and renal risk, plus increased sensitivity to fluid retention and BP elevation, make NSAIDs a cautious choice in older adults.
Reducing GI risk: If you must take an NSAID and have GI risk factors, always take it with food. Consider co-prescribing a proton pump inhibitor (omeprazole, pantoprazole). Use the lowest effective dose for the shortest necessary duration. Ask about topical options for localized joint pain — Voltaren Gel delivers anti-inflammatory effect locally with substantially lower systemic exposure.
Important Drug Interactions
NSAIDs interact meaningfully with several drug classes that are commonly co-prescribed:
Warfarin and Other Anticoagulants
NSAIDs impair platelet function and can displace warfarin from protein binding sites, significantly raising bleeding risk. This is one of the most clinically important drug interactions in ambulatory medicine. See our detailed article on warfarin and ibuprofen for the full breakdown.
ACE Inhibitors, ARBs, and Diuretics (the "Triple Whammy")
The combination of an ACE inhibitor (lisinopril, enalapril), an ARB (losartan, valsartan), and an NSAID — sometimes called the "triple whammy" when a diuretic is added — dramatically increases the risk of acute kidney injury. NSAIDs reduce renal prostaglandin synthesis, which constricts the afferent arterioles feeding the glomerulus. When combined with agents that dilate the efferent arterioles (ACE inhibitors and ARBs), the glomerular filtration pressure drops sharply. NSAIDs also blunt the antihypertensive effect of these drugs, raising blood pressure.
SSRIs and SNRIs
Selective serotonin reuptake inhibitors (sertraline, fluoxetine, escitalopram) impair platelet serotonin uptake, reducing platelet aggregation. Combined with NSAIDs' platelet inhibition, the risk of upper GI bleeding increases by three to fifteen times compared to either drug alone.
Methotrexate
NSAIDs reduce renal clearance of methotrexate, a chemotherapy and autoimmune disease drug. This can raise methotrexate to toxic levels, causing serious bone marrow and GI toxicity. Patients on methotrexate are typically counseled to avoid NSAIDs entirely, or to use them only with very close monitoring.
Lithium
NSAIDs reduce renal prostaglandin synthesis and decrease lithium clearance, causing lithium levels to rise. Lithium toxicity — manifesting as tremor, confusion, and cardiac arrhythmias — can develop over days in patients who start a new NSAID. Lithium levels should be checked promptly after initiating or changing NSAIDs.
Frequently Asked Questions
What are NSAIDs and how do they work?
NSAIDs — non-steroidal anti-inflammatory drugs — reduce pain, inflammation, and fever by inhibiting cyclooxygenase (COX) enzymes, which are responsible for producing prostaglandins, the chemical messengers that trigger inflammation, sensitize pain receptors, and promote fever. Common NSAIDs include ibuprofen (Advil, Motrin), naproxen (Aleve), aspirin, and prescription-strength options like celecoxib, meloxicam, and indomethacin. Unlike acetaminophen, NSAIDs directly address inflammation, not just pain perception.
What are the most important risks of taking NSAIDs regularly?
The three most clinically significant risks of regular NSAID use are gastrointestinal (stomach ulcers and GI bleeding), cardiovascular (elevated blood pressure and increased risk of heart attack and stroke, particularly with non-aspirin NSAIDs), and renal (reduced kidney blood flow, which can cause acute kidney injury especially in people with pre-existing kidney disease, heart failure, or who are dehydrated). These risks increase with higher doses, longer duration of use, and in older adults.
What is the difference between ibuprofen and naproxen?
Both are non-selective NSAIDs that inhibit COX-1 and COX-2 enzymes, but they differ primarily in duration of action. Ibuprofen has a short half-life (1.8–3.5 hours) and typically requires dosing every 4–6 hours for sustained anti-inflammatory effect. Naproxen's much longer half-life (12–17 hours) allows for twice-daily dosing and may provide more consistent anti-inflammatory coverage for conditions like arthritis. For acute pain, either can be effective; for chronic inflammatory conditions, naproxen's longer duration is often preferred.
Can NSAIDs be taken safely long-term?
Regular long-term NSAID use carries meaningful cumulative risks, particularly GI and cardiovascular. For patients who require ongoing NSAID therapy for arthritis or chronic pain, co-prescription of a proton pump inhibitor (like omeprazole) is often recommended to reduce GI bleeding risk. Patients with cardiovascular disease, kidney disease, or a history of peptic ulcers require careful risk-benefit assessment before long-term NSAID use. Celecoxib (a selective COX-2 inhibitor) may carry lower GI risk than non-selective NSAIDs but is not risk-free.
Check for NSAID interactions with your other medications
Open the Interaction Checker →